Quanterix Corporation Announces New Board Members as Mendel and Lai-Goldman Join Leadership Team Following Akoya Acquisition
Quanterix Corporation has announced changes to its Board of Directors following the acquisition of Akoya Biosciences. Scott Mendel and Myla Lai-Goldman, MD, have been appointed to the board, replacing Martin D. Madaus, PhD, and Sarah Hlavinka. Masoud Toloue will continue as Chief Executive Officer, and Vandana Sriram will remain as Chief Financial Officer.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quanterix Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250707828058) on July 08, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。